UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Methods in molecular biology (Clifton, N.J.), 2009, Vol.542, p.565

2009

Link zum Volltext

Verfügbarkeit prüfen

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Journal of Virology, 2009-08, Vol.83 (16), p.8108-8121

2009

Link zum Volltext

Verfügbarkeit prüfen

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Expert review of vaccines, 2014-01, Vol.13 (1), p.117-130

2014

Link zum Volltext

Verfügbarkeit prüfen

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2013-02, Vol.27 (1), p.35-53

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.587-598

Schirrmacher, Volker

2005

Link zum Volltext

Verfügbarkeit prüfen

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Cancer gene therapy, 2005-03, Vol.12 (3), p.295-303

2005

Link zum Volltext

Verfügbarkeit prüfen

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

Expert review of anticancer therapy, 2020-08, Vol.20 (8), p.639-646

2020

Link zum Volltext

Verfügbarkeit prüfen

Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

Cancer gene therapy, 2000-02, Vol.7 (2), p.316-323

2000

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Virus research, 2008-09, Vol.136 (1), p.75-80

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

Immunotherapy, 2015-08, Vol.7 (8), p.855-860

2015

Link zum Volltext

Verfügbarkeit prüfen

Induction of Interferon-α and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Blood Mononuclear Cells by Hemagglutinin-Neuraminidase but Not F Protein of Newcastle Disease Virus

Virology (New York, N.Y.), 2002-05, Vol.297 (1), p.19-30

2002

Link zum Volltext

Verfügbarkeit prüfen

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

International immunology, 1996-04, Vol.8 (4), p.491-498

1996

Link zum Volltext

Verfügbarkeit prüfen

An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

Cancer gene therapy, 1999-05, Vol.6 (3), p.254-262

1999

Link zum Volltext

Verfügbarkeit prüfen

Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.8057-8061

2004

Link zum Volltext

Verfügbarkeit prüfen

A tumor vaccine containing anti‐CD3 and anti‐CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

International journal of cancer, 2006-02, Vol.118 (3), p.658-667

2006

Link zum Volltext

Verfügbarkeit prüfen

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine

Vaccine, 2005-03, Vol.23 (19), p.2439-2453

2005

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of human natural interferon-α response via paramyxovirus hemagglutinin lectin-cell interaction

Journal of molecular medicine (Berlin, Germany), 2002-07, Vol.80 (7), p.443-451

2002

Link zum Volltext

Verfügbarkeit prüfen

Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation

Methods in molecular biology (Clifton, N.J.), 2012, Vol.797, p.177

2012

Link zum Volltext

Verfügbarkeit prüfen

Modification of cancer vaccines by virus infection and attachment of bispecific antibodies. An effective alternative to somatic gene therapy

Advances in experimental medicine and biology, 1998, Vol.451, p.251

1998

Link zum Volltext

Verfügbarkeit prüfen

Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine

Clinical cancer research, 1998-03, Vol.4 (3), p.721-730

1998

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodies

Cancer Immunology, Immunotherapy, 1996-11, Vol.43 (3), p.190-194

1996

Link zum Volltext

Verfügbarkeit prüfen

Viral hemagglutinin augments peptide‐specific cytotoxic T cell responses

European journal of immunology, 1993-10, Vol.23 (10), p.2592-2596

1993

Link zum Volltext

Verfügbarkeit prüfen

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

International journal of cancer, 1994-12, Vol.59 (6), p.796-801

1994

Link zum Volltext

Verfügbarkeit prüfen

Postoperative active specific immunization in colorectal cancer patients with virus‐modified autologous tumor‐cell vaccine. First clinical results with tumor‐cell vaccines modified with live but avirulent newcastle disease virus

Cancer, 1990-10, Vol.66 (7), p.1517-1523

1990

Link zum Volltext

Verfügbarkeit prüfen

Biotherapy of cancer : perspectives of immunotherapy and gene therapy

Journal of cancer research and clinical oncology, 1995-08, Vol.121 (8), p.443-451

SCHIRRMACHER, V

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaNewcastle Disease Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

Induction of Interferon-α and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Blood Mononuclear Cells by Hemagglutinin-Neuraminidase but Not F Protein of Newcastle Disease Virus

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells

A tumor vaccine containing anti‐CD3 and anti‐CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine

Stimulation of human natural interferon-α response via paramyxovirus hemagglutinin lectin-cell interaction

Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation

Modification of cancer vaccines by virus infection and attachment of bispecific antibodies. An effective alternative to somatic gene therapy

Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine

Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodies

Viral hemagglutinin augments peptide‐specific cytotoxic T cell responses

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

Postoperative active specific immunization in colorectal cancer patients with virus‐modified autologous tumor‐cell vaccine. First clinical results with tumor‐cell vaccines modified with live but avirulent newcastle disease virus

Biotherapy of cancer : perspectives of immunotherapy and gene therapy

Aktive Filter

Suchergebnisse filtern